在癌症中发现与补体相关的生物标志物的洞察和观点
Daniel Ajona1, Janire Debersaques2, Ruben Pio1
1Laboratory of Translational Oncology, Program in Solid Tumors, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain; Department of Biochemistry and Genetics, School of Sciences, Universidad de Navarra, Pamplona, Spain; Navarra's Health Research Institute (IDISNA), Pamplona, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain.
Current opinion in immunology
|August 6, 2025
概括
补充系统蛋白质显示出作为癌症生物标志物用于诊断和治疗的前景. 标准化和验证方面的挑战阻碍了临床使用,但未来的研究旨在克服这些障碍,以获得更好的癌症治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物标志物发现发现
背景情况:
- 补体系统是天生的免疫系统的一部分,在瘤进展,免疫逃避和治疗反应中发挥作用.
- 在癌症患者中观察到补充成分的变化,这表明生物标志物的潜力.
研究的目的:
- 审查有关瘤学中补充相关生物标志物的当前知识.
- 突出挑战,并讨论临床翻译的未来方向.
主要方法:
- 对癌症生物学和生物标志物研究中的补充系统现有文献的审查.
- 分析标准化,验证和临床整合方面的挑战.
主要成果:
- 补充衍生的生物标志物显示出癌症诊断,预后和治疗指导的潜力.
- 由于技术和概念上的挑战,目前在常规瘤实践中没有补充相关的生物标志物.
结论:
- 标准化测试和参考材料对于可靠的补充生物标志物开发至关重要.
- 与人工智能和放射学等其他工具的整合是癌症护理临床实用性的关键.
相关概念视频
Complement System
2.7K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.7K
Selectins
3.4K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.4K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K


